NEPH News and Press, Nephros Inc. From 10/08/21

Anticipates Net Revenue of $2.6 Million, a 24% Year-Over-Year Increase SOUTH ORANGE, NJ - ( NewMediaWire ) - October 08, 2021 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, to...

SOUTH ORANGE, NJ - ( NewMediaWire ) - October 05, 2021 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced it has been selected to present at the  14thAnn...

SOUTH ORANGE, NJ, Oct. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced it has been selecte...

SOUTH ORANGE, NJ - ( NewMediaWire ) - September 15, 2021 - Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced it has been selected to present at the 6th annual&...

SOUTH ORANGE, NJ - ( NewMediaWire ) - September 01, 2021 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced the appointment of Wes Lobo to the role of Chie...

Nephros, Inc. (NEPH) Q2 2021 Earnings Conference Call August 05, 2021, 16:30 ET Company Participants Kirin Smith - ProActive Capital Group Andrew Astor - CEO, CFO, President & Director Conference Call Participants Marc Wiesenberger - B. Riley Securities Presentation Operator Good day, and...

Nephros (NASDAQ:NEPH): Q2 GAAP EPS of -$0.12 misses by $0.01. Revenue of $2.3M (+45.6% Y/Y) beats by $0.09M. Adjusted EBITDA improved by 46% to -$0.8M. Press Release For further details see: Nephros EPS misses by $0.01, beats on revenue

Second Quarter Net Revenue of $2.3 Million; 44% Year-Over-Year Increase; Strategic Acquisition of GenArraytion, Inc.; HDF Product Submitted to FDA for 510(k) Clearance SOUTH ORANGE, NJ - ( NewMediaWire ) - August 05, 2021 - Nephros, Inc. (Nasdaq: NEPH), a leading biotechnology ...

GenArraytion is a recognized market leader in infectious disease monitoring and measurement.This addition will give Nephros (NEPH) access to GenArraytion’s many proprietary assays, multiplexing technology, and selection methods for detecting waterborne pathogens, and other microorganis...

Strategic Acquisition Accelerates Pathogen Detection Product Development SOUTH ORANGE, NJ, July 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to th...